Global, regional, and national burden of acute glomerulonephritis from 1990 to 2021 and future trend predictions until 2036: a systematic analysis using the Global Burden of Disease Study 2021
Frontiers in Public Health · 2025
DOI: 10.3389/fpubh.2025.1593055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2025. Verfasst von Yangtian Jiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Glomerulonephritis, Global Burden of Disease, Global Health. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
This study aimed to analyze the global, regional, and national burden of acute glomerulonephritis (AGN) from 1990 to 2021 and project its trends through 2036 using data from the Global Burden of Disease (GBD) study.
Methods
Using the GBD 2021 dataset, we evaluated the burden of AGN in terms of incidence, mortality, and disability-adjusted life years (DALYs). Age-standardized rates (ASRs) were calculated, and trends were assessed using the Estimated Annual Percentage Change (EAPC) measure. Decomposition analysis quantified the contributions of population growth, aging, and epidemiological changes. Projections for AGN burden were modeled using the Auto-Regressive Integrated Moving Average (ARIMA) approach.
Results
From 1990 to 2021, the global age-standardized incidence rate (ASIR) of AGN declined by 46.09%, and the age-standardized DALY rate decreased by 65.87%. Middle-Socio-Demographic Index (SDI) regions exhibited the highest burden, while high-SDI regions showed increasing trends in mortality and DALY, potentially linked to autoimmune and systemic conditions. Decomposition analysis highlighted the role of epidemiological improvements, balanced by the impacts of population growth and aging. Projections indicate a continued global decline, with a 43.81% reduction in the ASIR and a 62.92% decline in the age-standardized DALY rate by 2036.
Conclusion
Despite significant global progress, disparities persist, particularly in low- and middle-income regions. Targeted interventions, enhanced diagnostic capabilities, and strategies that address socioeconomic determinants are essential to achieving a equitable reduction in the AGN burden. This study emphasizes the importance of global and regional strategies in improving AGN outcomes worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, China-Japan Friendship Hospital, Beijing, China.
- China-Japan Friendship Hospital, Beijing, China.
- Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
- Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Key Laboratory of Genetics and Molecular Mechanism of Cardiological Disorders, Wuhan, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiao, Y., Chen, X., Zhang, T., Ma, C., Shen, C., & Yu, B. (2025). Global, regional, and national burden of acute glomerulonephritis from 1990 to 2021 and future trend predictions until 2036: a systematic analysis using the Global Burden of Disease Study 2021. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1593055
Vancouver
Jiao Y, Chen X, Zhang T, Ma C, Shen C, Yu B. Global, regional, and national burden of acute glomerulonephritis from 1990 to 2021 and future trend predictions until 2036: a systematic analysis using the Global Burden of Disease Study 2021. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1593055
BibTeX
@article{Jiao2025,
author = {Jiao, Yangtian and Chen, Xing and Zhang, Tianyu and Ma, Changyu and Shen, Congrong and Yu, Bo},
title = {Global, regional, and national burden of acute glomerulonephritis from 1990 to 2021 and future trend predictions until 2036: a systematic analysis using the Global Burden of Disease Study 2021},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1593055}
}
EUVIMED